微动脉瘤反射特征可预测糖尿病视网膜病变玻璃体腔治疗反应
高反射型患者完全视网膜内液吸收率为51.3%,低反射型仅7.4%(P < .001),MA反射表型是治疗反应的唯一独立预测因子(OR 13.50,95%CI 2.87-63.51,p < .001)。
要点
- SD-OCT微动脉瘤反射表型与DME抗VEGF或地塞米松植入治疗反应显著相关。
- 高反射为主型完全积液吸收率51.3%,低反射为主型仅7.4%。
- MA反射表型是治疗反应的唯一独立预测因子(OR 13.50)。
核心结论
- SD-OCT上的微动脉瘤反射表型可能是DME治疗反应的有用预测指标。
- 高反射表型患者的积液完全吸收率显著高于低反射表型,且独立于患者特征和治疗方式。
研究设计与样本
- 基于SD-OCT对中央3 mm ETDRS区内所有微动脉瘤的内部反射进行分类:高反射为主型(>50%高反射MA)或低反射为主型(>50%低反射MA)。
- 患者接受玻璃体腔抗VEGF治疗或地塞米松植入,随访12个月,主要结局为12个月时完全视网膜内液吸收。
主要发现
- 基线时39例(59.1%)为高反射表型,27例(40.9%)为低反射表型。
- 高反射表型组20/39例(51.3%)达到完全积液吸收,低反射表型组仅2/27例(7.4%),P < .001。
- 多因素logistic回归显示表型分类是治疗反应的唯一独立预测因子(OR 13.50,95%CI 2.87-63.51,p < .001)。
关键数值与推荐
- 高反射表型定义为>50%微动脉瘤呈高反射;低反射表型定义为>50%微动脉瘤呈低反射。
- 完全积液吸收率:高反射表型51.3% vs 低反射表型7.4%(P < .001)。
- 独立预测因子OR 13.50(95%CI 2.87-63.51,p < .001)。
临床怎么用
- 临床可基于SD-OCT微动脉瘤反射表型对DME患者进行分层,预判抗VEGF或地塞米松植入的治疗反应。
- 高反射为主型患者可能更易获得完全积液吸收,低反射为主型患者可能需要更积极或替代治疗策略。
局限性
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate whether baseline reflectivity patterns of diabetic microaneurysms (MAs) on spectral-domain optical coherence tomography (SD-OCT) predict treatment response in diabetic macular edema (DME). DESIGN: Retrospective clinical cohort study. METHODS: Sixty-six patients with treatment-naive DME were analyzed. All microaneurysms within the central 3 mm ETDRS area were identified and classified based on internal reflectivity on SD-OCT. Patients were categorized into 2 phenotypic groups based on the predominant reflectivity pattern: predominantly hyperreflective phenotype (>50% hyperreflective MAs) or predominantly hyporeflective phenotype (>50% hyporeflective MAs). Patients received intravitreal anti-VEGF therapy or dexamethasone implants over 12 months. The primary outcome was complete intraretinal fluid resolution at 12-month follow-up. RESULTS: Thirty-nine patients (59.1%) were classified as hyperreflective phenotype and 27 (40.9%) as hyporeflective phenotype at baseline. Complete fluid resolution was achieved in 20 of 39 hyperreflective phenotype patients (51.3%) compared to 2 of 27 hyporeflective phenotype patients (7.4%, P < .001). Multivariate logistic regression confirmed phenotype classification as the only independent predictor of treatment response (OR 13.50, 95% CI 2.87-63.51, p < .001). CONCLUSIONS: Microaneurysm reflectivity phenotype on SD-OCT may serve as a useful predictor of treatment response in DME. Hyperreflective phenotype demonstrated significantly higher rates of fluid resolution compared to hyporeflective phenotype, independent of patient characteristics and treatment modality.
引用
- Viggiano P, Carra A, Bruno G, et al. Microaneurysm Reflectivity as a Prognostic Biomarker for Intravitreal Treatment Response in Diabetic Retinopathy. Am J Ophthalmol. 2026. PMID: 41617122. doi:10.1016/j.ajo.2026.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。